| scholarly article | Q13442814 |
| P2093 | author name string | K B Thor | |
| H Danuser | |||
| P2860 | cites work | International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) | Q28239487 |
| Serotoninergic, noradrenergic, and peptidergic innervation of Onuf's nucleus of normal and transected spinal cords of baboons (Papio papio) | Q30989339 | ||
| Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. | Q34188771 | ||
| Inhibition of central sympathetic and somatic outflow to the lower urinary tract of the cat by the alpha 1 adrenergic receptor antagonist prazosin | Q39475903 | ||
| Serotonergic facilitation of facial motoneuron excitation | Q39887089 | ||
| Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents | Q41333360 | ||
| Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat. | Q41923358 | ||
| The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo | Q41983990 | ||
| Effects of 5-hydroxytryptamine agonists and antagonists on the responses of rat spinal motoneurones to raphe obscurus stimulation | Q42128652 | ||
| Behaviour of the urethral striated sphincter and of the bladder in the chronic spinal cat. Implications at the Central Nervous System Level | Q43673393 | ||
| α2-Adrenoceptors not imidazole receptors mediate depression of a sacral spinal reflex in the cat | Q43745294 | ||
| 5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell column | Q43787432 | ||
| Organization of afferent and efferent pathways in the pudendal nerve of the female cat. | Q45183796 | ||
| Effects of central serotonin on autonomic control of heart rate in intact and baroreceptor deficient rats | Q45225516 | ||
| Organization of the nervous control of urethral sphincter. A study in the anaesthetized cat with intact central nervous system | Q47968022 | ||
| Evidence for a serotonergically mediated sympathoexcitatory response to stimulation of medullary raphe nuclei | Q48613803 | ||
| Coincidence of ?ladder-like patterns? in distributions of monoaminergic terminals and sympathetic preganglionic neurons in the rat spinal cord | Q48810800 | ||
| Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine | Q48956020 | ||
| Serotonin excitation of facial motoneurons: receptor subtype characterization | Q49155580 | ||
| An excitatory action of 5-Hydroxytryptamine on sympathetic preganglionic neurones | Q51221252 | ||
| Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat | Q51597655 | ||
| Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat | Q51597666 | ||
| Characterization of DOI, a putative 5-HT2 receptor agonist in the rat. | Q51748864 | ||
| Evidence for a spinal site of action of clonidine on somatic and viscerosomatic reflex activity evoked on the pudendal nerve in cats | Q54380365 | ||
| Effects of clonidine on the lumbar sympathetic pathways to the large intestine and urinary bladder of the cat | Q66972323 | ||
| Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats | Q68213058 | ||
| Reflex firing in the lumbar sympathetic outflow to activation of vesical afferent fibres* | Q69006180 | ||
| The spinal distribution of sympathetic preganglionic and visceral primary afferent neurons that send axons into the hypogastric nerves of the cat | Q70018015 | ||
| LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat | Q70170709 | ||
| Immunohistochemical study on the localization of serotonin fibers and terminals in the spinal cord of the monkey (Macaca fuscata) | Q70244945 | ||
| Can the 5-HT2/1c agonist DOI cause differential sympatho-excitation in nerves supplying the heart in anaesthetized cats? | Q70568870 | ||
| Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline | Q71179801 | ||
| Central distribution of afferent and efferent components of the pudendal nerve in cat | Q71276175 | ||
| Immunohistochemical study on the distribution of serotonin fibers in the spinal cord of the dog | Q71452459 | ||
| The segmental detailed topographical distribution of monoaminergic terminals and their pathways in the spinal cord of the cat | Q71463397 | ||
| 5-Hydroxytryptamine2a, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human | Q72110352 | ||
| Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord | Q72878525 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 150-154 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. | |
| P478 | volume | 118 |
| Q28575935 | 5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT7 and 5-HT2C receptors |
| Q35545746 | Animal models in urological disease and sexual dysfunction |
| Q33604488 | Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder |
| Q43158734 | Characterization of a spinal, urine storage reflex, inhibitory center and its regulation by 5-HT1A receptors in female cats |
| Q43614787 | Clozapine inhibits micturition parameters and the external urethral sphincter during cystometry in anesthetized rats |
| Q44054332 | Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats |
| Q44591404 | Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence |
| Q33316575 | Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial |
| Q44763401 | Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence |
| Q44756644 | Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial |
| Q35207634 | Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence |
| Q80297283 | Duloxetine: a summary of published clinical experience |
| Q36807085 | Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. |
| Q24805130 | Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats |
| Q34151459 | External urethral sphincter motoneuron properties in adult female rats studied in vitro |
| Q81301566 | Impact of duloxetine on quality of life for women with symptoms of urinary incontinence |
| Q43990710 | Influence of central serotonergic mechanisms on lower urinary tract function |
| Q79368285 | Innovations in pharmacotherapy for stress urinary incontinence |
| Q34792786 | Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat. |
| Q36274100 | Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury |
| Q35687988 | Mixed incontinence |
| Q37739966 | Mixed incontinence: current evidence and future perspectives |
| Q34085595 | Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles |
| Q26828785 | Neural control of the lower urinary tract |
| Q34020395 | Neural control of the lower urinary tract: peripheral and spinal mechanisms |
| Q35112468 | Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence |
| Q36290129 | Neurobiology of stress urinary incontinence: new insights and implications for treatment |
| Q37992131 | Neurophysiology and therapeutic receptor targets for stress urinary incontinence |
| Q80297261 | Neurophysiology of stress urinary incontinence |
| Q47616467 | Noradrenergic Mechanisms Controlling Urethral Smooth and Striated Muscle Function in Urethral Continence Reflex in Rats |
| Q51698804 | Peripheral neural lesion-induced stress urinary incontinence in anaesthetized female cats. |
| Q80296012 | Pharmacotherapy for stress urinary incontinence |
| Q35826270 | Pharmacotherapy for stress urinary incontinence : present and future options |
| Q42848230 | Properties of urethral rhabdosphincter motoneurons and their regulation by noradrenaline |
| Q33727827 | Role of 5-HT1A receptors in control of lower urinary tract function in anesthetized rats |
| Q37114348 | Role of alpha2-adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats |
| Q35771624 | Role of serotonin and noradrenaline in stress urinary incontinence |
| Q37417232 | Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats |
| Q51517655 | Role of vasopressin V(₁A) receptor in the urethral closure reflex in rats. |
| Q35037144 | Roles of glutamatergic and serotonergic mechanisms in reflex control of the external urethral sphincter in urethane-anesthetized female rats |
| Q35556299 | Serotonergic modulation of bladder afferent pathways |
| Q48430391 | Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats |
| Q28575282 | Serotonin 5-HT2A and 5-HT5A receptors are expressed by different motoneuron populations in rat Onuf's nucleus |
| Q36869316 | Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine |
| Q35556294 | Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence |
| Q83448708 | The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons |
| Q80297253 | The pathophysiology of stress urinary incontinence: a historical perspective |
| Q44077125 | The role of 5-HT(1A) receptors in control of lower urinary tract function in cats |
| Q35545729 | The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition |
| Q37011767 | Therapeutic receptor targets for lower urinary tract dysfunction |
| Q55496367 | Urinary incontinence: its assessment and relationship to depression among community-dwelling multiethnic older women. |
| Q34399692 | α(2)-Adrenoceptors as a new target for stress urinary incontinence |
Search more.